25922 Search Results


escherichia coli  (ATCC)
99
ATCC escherichia coli
Escherichia Coli, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/10__18051_slash_univmed__2024__v43__220___228-37-13-15
Average 99 stars, based on 1 article reviews
escherichia coli - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
25922  (LGC Standards)
99
LGC Standards 25922
25922, supplied by LGC Standards, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/25922/custom%4025922%4029359692
Average 99 stars, based on 1 article reviews
25922 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
escherichia coli migula castellani  (ATCC)
99
ATCC escherichia coli migula castellani
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
Escherichia Coli Migula Castellani, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pm31243989-156-29-35
Average 99 stars, based on 1 article reviews
escherichia coli migula castellani - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
e coli atcc 25922  (ATCC)
99
ATCC e coli atcc 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/Escherichia+coli/10__18231_slash_j__ijmr__2024__032-53-5-7
Average 99 stars, based on 1 article reviews
e coli atcc 25922 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
escherichia coli lb 25922  (Laborclin BR)
90
Laborclin BR escherichia coli lb 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
Escherichia Coli Lb 25922, supplied by Laborclin BR, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/e++coli+25922/pmc11940099-48-43-59
Average 90 stars, based on 1 article reviews
escherichia coli lb 25922 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
e. coli 25922  (Becton Dickinson)
90
Becton Dickinson e. coli 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
E. Coli 25922, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/e++coli+25922/pmc11430396-98-0-3
Average 90 stars, based on 1 article reviews
e. coli 25922 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
e. coliatcc strain 25922  (HiMedia Laboratories)
90
HiMedia Laboratories e. coliatcc strain 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
E. Coliatcc Strain 25922, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/e++coliatcc+strain+25922/pm26779134-120-0-8
Average 90 stars, based on 1 article reviews
e. coliatcc strain 25922 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
escherichia coli atc 25922  (HiMedia Laboratories)
90
HiMedia Laboratories escherichia coli atc 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
Escherichia Coli Atc 25922, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/escherichia+coli+atc+25922/pm36297565-45-7-21
Average 90 stars, based on 1 article reviews
escherichia coli atc 25922 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
escherichia coli 25922  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection escherichia coli 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
Escherichia Coli 25922, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/escherichia+coli+25922/10__1016_slash_j__powtec__2010__09__003-36-0-5
Average 90 stars, based on 1 article reviews
escherichia coli 25922 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
escherichia coli actt 25922  (Sancordon Inc)
90
Sancordon Inc escherichia coli actt 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
Escherichia Coli Actt 25922, supplied by Sancordon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/escherichia+coli+actt+25922/pm18624950-60-10-14
Average 90 stars, based on 1 article reviews
escherichia coli actt 25922 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
e. coliatcc 25922  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute e. coliatcc 25922
Figure 3 Growth of <t>E</t> <t>coli</t> strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.
E. Coliatcc 25922, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/25922/e++coliatcc+25922/pm24239909-41-13-5
Average 90 stars, based on 1 article reviews
e. coliatcc 25922 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Figure 3 Growth of E coli strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.

Journal: ACS infectious diseases

Article Title: Detection of "Hidden" Antimicrobial Drug Resistance.

doi: 10.1021/acsinfecdis.9b00132

Figure Lengend Snippet: Figure 3 Growth of E coli strains and other clinically isolated infectious bacteria: (Upper- panel A-L): growth curve tracked by EZMTT method; (Lower-panel a-l): growth curve tracked by turbidity method; doubling times at the log phase measured by the EZMTT and by the turbidity methods were A) 0.80±0.11h and 0.79±0.10 h for DH5α, respectively; B) 1.4±0.4 h and 1.6±0.3 h for MG1655 (wild type E. coli), respectively; C) 0.42±0.06 h and 0.42±0.08 h for EAEC ( adhesive E. coli), respectively; D) 0.40±0.11 h and 0.40±0.07 h for EIEC (invasive E. coli); E) 0.43±0.09 h and 0.42±0.09 h for EPEC (pathogenic E. coli), F) 0.41±0.05 h and 0.40±0.07 h for ETEC (toxigenic E. coli), respectively; G) 0.72±0.23 h and 0.74±0.06 h for Salmonella, respectively; H) 0.80±0.10 h and 0.71±0.08 h for Salmonella paratyphi, respectively; I) 1.33±0.14 h and 0.82±0.20 h for Shigella flexneri, respectively; J) 1.17±0.02 h and 1.30±0.27 h for Shigella sonnei, respectively; K) 0.50±0.07 h and 0.49±0.06 h for Staphylococcus aureus, respectively; L) 0.42±0.08 h and 0.47±0.18 h for Bacillus cereus, respectively.

Article Snippet: Mueller-Hinton Broth was purchased from OXOID(Hampshire,U.K;Chemicals from Sigma (USA), EZMTT purchased from JNF Bioscience (China; USA), CCK-8 or WST-8 from Beyotime Biotechnology (China), Enterococcus casseliflavus Collins et al. ATCC700327, Escherichia coli (Migula) Castellani and Chalmers ATCC 25922,Pseudomonas aeruginosa (Schroeter) Migula ATCC 27853,Staphylococcus aureus subsp. aureus Rosenbach ATCC 25923 were purchased from ATCC (USA).

Techniques: Isolation, Bacteria, Adhesive

Figure 5. AST of antibiotics in clinically isolated A) E. coli (B) Staphylococcus aureus and (C) Bacillus cereus strains (2 10 CFU/ml) using the turbidity and the EZMTT methods; (AMP, KAN, GEN) DIP curves collected by the turbidity and the EZMTT methods; (5 hrs, 16 hrs) z-factors measured using the absorbance of OD750 nm in the turbidity assay and the absorbance of OD450 nm in the EZMTT assay at both the 5 hrs and the 16 hrs time points, respectively (z factor > 0.5 indicates excellent reproducibility; calculation z =1-[(3SD of high control)+(3SD of low control)]/[(mean of high control)-(mean of low control)]); (IC50) IC50 curves collected at the 24 hrs time point by the turbidity (black curve), the EZMTT (red curve) and the MTT methods (blue curve), showing essentially the same AST results, but the EZMTT assay showed much better assay precision.

Journal: ACS infectious diseases

Article Title: Detection of "Hidden" Antimicrobial Drug Resistance.

doi: 10.1021/acsinfecdis.9b00132

Figure Lengend Snippet: Figure 5. AST of antibiotics in clinically isolated A) E. coli (B) Staphylococcus aureus and (C) Bacillus cereus strains (2 10 CFU/ml) using the turbidity and the EZMTT methods; (AMP, KAN, GEN) DIP curves collected by the turbidity and the EZMTT methods; (5 hrs, 16 hrs) z-factors measured using the absorbance of OD750 nm in the turbidity assay and the absorbance of OD450 nm in the EZMTT assay at both the 5 hrs and the 16 hrs time points, respectively (z factor > 0.5 indicates excellent reproducibility; calculation z =1-[(3SD of high control)+(3SD of low control)]/[(mean of high control)-(mean of low control)]); (IC50) IC50 curves collected at the 24 hrs time point by the turbidity (black curve), the EZMTT (red curve) and the MTT methods (blue curve), showing essentially the same AST results, but the EZMTT assay showed much better assay precision.

Article Snippet: Mueller-Hinton Broth was purchased from OXOID(Hampshire,U.K;Chemicals from Sigma (USA), EZMTT purchased from JNF Bioscience (China; USA), CCK-8 or WST-8 from Beyotime Biotechnology (China), Enterococcus casseliflavus Collins et al. ATCC700327, Escherichia coli (Migula) Castellani and Chalmers ATCC 25922,Pseudomonas aeruginosa (Schroeter) Migula ATCC 27853,Staphylococcus aureus subsp. aureus Rosenbach ATCC 25923 were purchased from ATCC (USA).

Techniques: Isolation, Control

Figure 6. DIP curves collected by the turbidity (OD600nm) and the EZMTT (OD450nm) methods, showing the growth inhibitions of the wild type E. coli (MG1655) and the clinically isolated E. coli strains (EAEC, EIEC, EPEC, ETEC, A) by 12 antibiotic medicine (Fig S1A, S1B). Results are representative of at least 3 experiments in duplicates.

Journal: ACS infectious diseases

Article Title: Detection of "Hidden" Antimicrobial Drug Resistance.

doi: 10.1021/acsinfecdis.9b00132

Figure Lengend Snippet: Figure 6. DIP curves collected by the turbidity (OD600nm) and the EZMTT (OD450nm) methods, showing the growth inhibitions of the wild type E. coli (MG1655) and the clinically isolated E. coli strains (EAEC, EIEC, EPEC, ETEC, A) by 12 antibiotic medicine (Fig S1A, S1B). Results are representative of at least 3 experiments in duplicates.

Article Snippet: Mueller-Hinton Broth was purchased from OXOID(Hampshire,U.K;Chemicals from Sigma (USA), EZMTT purchased from JNF Bioscience (China; USA), CCK-8 or WST-8 from Beyotime Biotechnology (China), Enterococcus casseliflavus Collins et al. ATCC700327, Escherichia coli (Migula) Castellani and Chalmers ATCC 25922,Pseudomonas aeruginosa (Schroeter) Migula ATCC 27853,Staphylococcus aureus subsp. aureus Rosenbach ATCC 25923 were purchased from ATCC (USA).

Techniques: Isolation